Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice
- 1 February 1991
- Vol. 67 (3) , 643-648
- https://doi.org/10.1002/1097-0142(19910201)67:3<643::aid-cncr2820670320>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Bisphosphonates and bone metastasesBritish Journal of Cancer, 1988
- A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodiumZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- The Walker 256/B carcinosarcoma in thyroparathyroidectomized rats: A model to evaluate inhibitors of bone resorptionCalcified Tissue International, 1987
- Monitoring the treatment of paget's disease with etidronateCalcified Tissue International, 1984
- Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In VitroJournal of Clinical Investigation, 1982
- Apd in paget's disease of bone role of the mononuclear phagocyte system?Arthritis & Rheumatism, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- DiphosphonatesCalcified Tissue International, 1979
- Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivoScience, 1969